MDWD Institutional Ownership

MediWound Ltd.

Latest close $14.19 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing May 15, 2026
Public consensus preview Accumulation leaning 66/100 institutional research score
1 tracked institution Latest filing May 15, 2026

1 accumulating across 1 comparable institution.

Accumulating1
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$14.14 52-week high$22.51
Latest close $14.19 0.6% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Mar 31, 2026
T. Rowe Price Associates May 15, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 3 parsed filing(s)
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
T. Rowe Price Associates CIK0000080255 Mar 31, 2026 observed May 15, 2026 filed · 45d Initial Schedule 13G Initial Schedule 13G 709.8K +155.3K 12.00% 0.00 pts $16.11 $16.41 $14.19
T. Rowe Price Associates CIK0000080255 Dec 31, 2025 observed Feb 17, 2026 filed · 48d Schedule 13G amendment Reported reduction 554.5K -60.0K 12.00% 0.00 pts $18.46 $17.72 $14.19
T. Rowe Price Associates CIK0000080255 Sep 30, 2025 observed Nov 14, 2025 filed · 45d Initial Schedule 13G Initial Schedule 13G 614.5K 12.00% $18.02 $18.25 $14.19
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

SNX TD SYNNEX CORP 66/100 Accumulation leaning CBAN COLONY BANKCORP 66/100 Accumulation leaning NRIX Nurix Therapeutics, Inc. 66/100 Accumulation leaning VGNT VERSIGENT PLC 66/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026